Dividends, Financial Results, Presentation, Sale of Equity Stake, and Stock Purchase Agreements - Research Report on Sherwin-Williams, Ferro, Cytec, Methanex and Chemtura Editor Note: For more information about this release, please scroll to bottom. PR Newswire NEW YORK, October 29, 2013 NEW YORK, October 29, 2013 /PRNewswire/ -- Today, Analysts' Corner announced new research reports highlighting The Sherwin-Williams Company (NYSE: SHW), Ferro Corp. (NYSE: FOE), Cytec Industries Inc. (NYSE: CYT), Methanex Corp. (NASDAQ: MEOH), and Chemtura Corporation (NYSE: CHMT). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below. The Sherwin-Williams Company Research Report On October 16, 2013, Sherwin-Williams Company (Sherwin-Williams) announced that its Board of Directors has declared a regular quarterly dividend of $0.50 per common share, payable on December 6, 2013 to holders of record as on November 15, 2013. The Full Research Report on The Sherwin-Williams Company - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/4441_SHW] Ferro Corp. Research Report On October 23, 2013, Ferro Corp. (Ferro) reported its Q3 2013 financial results. The Company reported net sales of $408.1 million, representing a decline of 0.2% YoY. Net income attributable to common shareholders stood at $12.7 million or $0.15 per diluted share in Q3 2013, compared to a net loss of $316.1 million or $3.66 per share in Q3 2012. Adjusted diluted EPS stood at $0.14 during the quarter, compared to a net loss per share of $0.02 in Q3 2012. Peter Thomas, President and CEO of Ferro, commented, "We continue to make progress on our value creation strategy, making Ferro more competitive and driving increased profitability. We are realizing the benefits of our cost saving initiatives more quickly than previously anticipated and are now expecting total savings for 2013 to be approximately $45 million. More importantly, we estimate that our annual savings run rate at the beginning of 2014 will be approximately $70 million." The Company expects adjusted diluted EPS for Q4 2013 to be in the range of $0.04 to $0.07 and for full-year 2013 to be within $0.42 to $0.45. The Full Research Report on Ferro Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/e48f_FOE] Cytec Industries Inc. Research Report On October 18, 2013, Cytec Industries Inc. (Cytec) announced that it will showcase its premier line of UL certified electrical insulation resins at the Productronica 2013 in Munich, Germany, to be held from November 12 to November 15, 2013. The Company stated that electronics and electrical devices are increasingly utilized in applications that require performance in demanding environments such as dust, vibrations, moisture and extreme thermal cycles and as the industry's premier supplier of UL certified electrical insulation products, Cytec Formulated Resins has helped electronics and electrical device makers overcome these challenges for more than 50 years. Paolo Arnaboldi, Global Sales Director for Additive Technologies, stated, "Cytec offers one of the industry's largest portfolios of tested and certified potting, encapsulation and conformal coating resins in the market today. We are committed to applying our formulated science to help our customers leverage and optimize their businesses in the markets they serve." The Full Research Report on Cytec Industries Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/cf91_CYT] Methanex Corp. Research Report On October 22, 2013, Methanex Corp. (Methanex) announced that it has agreed to sell an approximate 10% of equity share in Egyptian Methanex Methanol Company S.A.E. (EMethanex) to Arab Petroleum Investments Corporation (APICORP) for $110 million. The Company informed that the transaction will increase APICORP's ownership in EMethanex to 17%, while Methanex will continue to be the operator and majority shareholder of EMethanex with an ownership of slightly more that 50%. John Floren, President and CEO of Methanex commented, "This is a win-win arrangement. The transaction aligns with APICORP's investment strategy, and EMethanex will benefit from APICORP's growing support. We are looking forward to continuing to build our relationship with APICORP. In Egypt, we have built a world-class methanol facility, and we believe our Egyptian operations will continue to create value for shareholders today and well into the future." The Full Research Report on Methanex Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/b01f_MEOH] Chemtura Corporation Research Report On October 10, 2013, Chemtura Corp. (Chemtura) announced that it has entered into a stock purchase agreement to sell its Consumer Products business, including dedicated manufacturing plants in the US and South Africa, to KIK Custom Products Inc. for $315 million in cash. Additionally, Chemtura informed that its board of directors has decided to explore a sale of the Company's agrochemicals business, Chemtura AgroSolutions. Craig A. Rogerson, Chairman, President and CEO of Chemtura said, "Following the sales of our Consumer Products and Antioxidants businesses, a sale of Chemtura AgroSolutions would transform Chemtura into a more focused, pure-play industrial specialty chemicals company with leading global positions that we believe can capitalize on attractive end-market growth trends, and continue delivering superior value to our shareholders and opportunities for our employees for many years to come." The Company informed that it anticipates to use a major portion of the proceeds from the sale of Consumer Products and expected sale of the agrochemicals business, to return capital to shareholders, to make important investments to strengthen, and to pay down debt in order to return towards its long-term stated total leverage target of approximately 2X Adjusted EBITDA. The Full Research Report on Chemtura Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/5f78_CHMT] EDITOR NOTES: 1.This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2.Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3.This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4.If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com. 5.For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com. 6.Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute. www.AnalystsCorner.com SOURCE Analysts' Corner Contact: CONTACT PERSON: Joe Thomas CONTACT PHONE: +1-310-496-8071 (North America)
Dividends, Financial Results, Presentation, Sale of Equity Stake, and Stock Purchase Agreements - Research Report on Sherwin
Press spacebar to pause and continue. Press esc to stop.